Mengistu Assegid, Gaeseb Johannes, Uaaka Gottfried, Ndjavera Christophine, Kambyambya Kennedy, Indongo Lazarus, Kalemeera Francis, Ntege Christopher, Mabirizi David, Joshi Mohan P, Sagwa Evans
Ministry of Health and Social Services, Windhoek, Namibia.
Namibia Institute for Pathology, Windhoek, Namibia.
J Pharm Policy Pract. 2013 Jun 13;6:4. doi: 10.1186/2052-3211-6-4. eCollection 2013.
Bacterial meningitis is a medical emergency associated with high mortality rates. Cerebrospinal fluid (CSF) culture is the "gold standard" for diagnosis of meningitis and it is important to establish the susceptibility of the causative microorganism to rationalize treatment. The Namibia Standard Treatment Guidelines (STGs) recommends initiation of empirical antibiotic treatment in patients with signs and symptoms of meningitis after taking a CSF sample for culture and sensitivity. The objective of this study was to assess the antimicrobial sensitivity patterns of microorganisms isolated from CSF to antibiotics commonly used in the empirical treatment of suspected bacterial meningitis in Namibia.
This was a cross-sectional descriptive study of routinely collected antibiotic susceptibility data from the Namibia Institute of Pathology (NIP) database. Results of CSF culture and sensitivity from January 1, 2009 to May 31, 2012, from 33 state hospitals throughout Namibia were analysed.
The most common pathogens isolated were Streptococcus species, Neisseria meningitidis, Haemophilus influenzae, Staphylococcus, and Escherichia coli. The common isolates from CSF showed high resistance (34.3% -73.5%) to penicillin. Over one third (34.3%) of Streptococcus were resistance to penicillin which was higher than 24.8% resistance in the United States. Meningococci were susceptible to several antimicrobial agents including penicillin. The sensitivity to cephalosporins remained high for Streptococcus, Neisseria, E. coli and Haemophilus. The highest percentage of resistance to cephalosporins was seen among ESBL K. pneumoniae (n = 7, 71%-100%), other Klebsiella species (n = 7, 28%-80%), and Staphylococcus (n = 36, 25%-40%).
The common organisms isolated from CSF were Streptococcus Pneumoniae, Neisseria meningitidis, Haemophilus influenzae, Staphylococcus, and E. coli. All common organisms isolated from CSF showed high sensitivity to cephalosporins used in the empirical treatment of meningitis. The resistance of the common isolates to penicillin is high. Most ESBL K. pneumoniae were isolated from CSF samples drawn from neonates and were found to be resistant to the antibiotics recommended in the Namibia STGs. Based on the above findings, it is recommended to use a combination of aminoglycoside and third-generation cephalosporin to treat non-ESBL Klebsiella isolates. Carbapenems (e.g., meropenem) and piperacillin/tazobactam should be considered for treating severely ill patients with suspected ESBL Klebsiella infection. Namibia should have a national antimicrobial resistance surveillance system for early detection of antibiotics that may no longer be effective in treating meningitis and other life-threatening infections due to resistance.
细菌性脑膜炎是一种死亡率很高的医疗急症。脑脊液(CSF)培养是脑膜炎诊断的“金标准”,确定致病微生物的药敏情况对于合理治疗很重要。纳米比亚标准治疗指南(STGs)建议,在采集脑脊液样本进行培养和药敏试验后,对有脑膜炎体征和症状的患者开始经验性抗生素治疗。本研究的目的是评估从脑脊液中分离出的微生物对纳米比亚疑似细菌性脑膜炎经验性治疗中常用抗生素的药敏模式。
这是一项横断面描述性研究,对纳米比亚病理研究所(NIP)数据库中常规收集的抗生素药敏数据进行分析。分析了2009年1月1日至2012年5月31日纳米比亚33家国立医院的脑脊液培养和药敏结果。
分离出的最常见病原体为链球菌属、脑膜炎奈瑟菌、流感嗜血杆菌、葡萄球菌和大肠杆菌。脑脊液中常见分离株对青霉素显示出高耐药性(34.3% - 73.5%)。超过三分之一(34.3%)的链球菌对青霉素耐药,高于美国24.8%的耐药率。脑膜炎球菌对包括青霉素在内的几种抗菌药物敏感。链球菌、奈瑟菌、大肠杆菌和流感嗜血杆菌对头孢菌素的敏感性仍然较高。肺炎克雷伯菌产超广谱β-内酰胺酶(ESBL)菌株(n = 7,71% - 100%)、其他克雷伯菌属菌株(n = 7,28% - 80%)和葡萄球菌(n = 36,25% - 40%)对头孢菌素的耐药率最高。
从脑脊液中分离出的常见病原体为肺炎链球菌、脑膜炎奈瑟菌、流感嗜血杆菌、葡萄球菌和大肠杆菌。从脑脊液中分离出的所有常见病原体对脑膜炎经验性治疗中使用的头孢菌素均显示出高敏感性。常见分离株对青霉素的耐药性较高。大多数产ESBL的肺炎克雷伯菌分离自新生儿脑脊液样本,且被发现对纳米比亚STGs推荐的抗生素耐药。基于上述发现,建议联合使用氨基糖苷类和第三代头孢菌素治疗非产ESBL的克雷伯菌分离株。对于疑似产ESBL克雷伯菌感染的重症患者,应考虑使用碳青霉烯类(如美罗培南)和哌拉西林/他唑巴坦。纳米比亚应建立国家抗菌药物耐药监测系统,以便早期发现因耐药而可能不再有效治疗脑膜炎和其他危及生命感染的抗生素。